Free tool
FAERS Monitor: Meropenem
Last checked: Nov 19, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 215212 or its brand name (Meropenem, Meropenem). Reports on generic versions are filed under their own applications.
Reports
32,715
Serious
31,766
97% of reports
Hospitalization
17,447
Death reported
9,722
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective4,620
- off label use3,390
- pyrexia2,230
- pneumonia1,510
- septic shock1,472
- sepsis1,429
- multiple organ dysfunction syndrome1,356
- acute kidney injury1,317
- condition aggravated1,295
- thrombocytopenia1,153
- febrile neutropenia1,149
- respiratory failure1,143
- diarrhoea1,139
- drug interaction986
- neutropenia960
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 101 |
| 2005 | 99 |
| 2006 | 135 |
| 2007 | 203 |
| 2008 | 228 |
| 2009 | 299 |
| 2010 | 409 |
| 2011 | 737 |
| 2012 | 788 |
| 2013 | 666 |
| 2014 | 658 |
| 2015 | 870 |
| 2016 | 1,203 |
| 2017 | 1,529 |
| 2018 | 2,137 |
| 2019 | 2,342 |
| 2020 | 2,810 |
| 2021 | 3,235 |
| 2022 | 2,870 |
| 2023 | 2,878 |
| 2024 | 3,227 |
| 2025 | 3,082 |
| 2026 | 2,206 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,021,444 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| multiple organ dysfunction syndromeSignal | 1,356 | 32.3 | 30.6 | 39,149 |
| septic shockSignal | 1,472 | 22.5 | 21.4 | 29,228 |
| febrile neutropeniaSignal | 1,149 | 11.3 | 10.7 | 10,641 |
| respiratory failureSignal | 1,143 | 10.2 | 9.6 | 9,382 |
| sepsisSignal | 1,429 | 8.3 | 7.9 | 9,141 |
| thrombocytopeniaSignal | 1,153 | 6.7 | 6.3 | 5,543 |
| acute kidney injurySignal | 1,317 | 5.6 | 5.3 | 4,930 |
| neutropeniaSignal | 960 | 4.6 | 4.3 | 2,667 |
| pyrexiaSignal | 2,230 | 4.2 | 4.0 | 5,412 |
| drug interactionSignal | 986 | 4.0 | 3.8 | 2,232 |
| pneumoniaSignal | 1,510 | 3.0 | 2.9 | 2,044 |
| condition aggravatedSignal | 1,295 | 2.7 | 2.6 | 1,451 |
| off label useSignal | 3,390 | 2.5 | 2.4 | 3,154 |
| drug ineffectiveSignal | 4,620 | 2.3 | 2.2 | 3,442 |
| diarrhoea | 1,139 | 1.1 | 1.1 | 19 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.